Loading …

Featured News

Something Special is Brewing at GSK Biopharm

Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi™

RoosterBio’s Got Plenty to Crow About

Cell Therapy to Replace All Modern Medicine?

Inova Discovery Series Attracts National Investors And Reveals New Consumer Health Findings

Published on : 13 Nov 2018
Published by : Gina Hagler

Cell Therapy to Replace All Modern Medicine?

Published on : 9 Nov 2018
Published by : Gina Hagler

New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium

Published on : 3 Oct 2018
Published by : Gina Hagler

This Company is On A Mission to Raise Credibility in Science

In the Trenches with RoosterBio’s Jon Rowley

GSK’s Head of Global Recruitment goes live on facebook – Sept 28th

In Conversation

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

Published on : 30 Oct 2018
Published by : Chris Frew

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by Medimmune & PerkinElmer (now Akoya Biosciences). After a successful first

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Published on : 9 Oct 2018
Published by : Chris Frew

Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD - The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech deals, especially in the immunotherapy market.  One deal, in particular,

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy

Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy

“In Conversation” with Mina Izadjoo, President of IPS

“In Conversation” with Mina Izadjoo, President of IPS

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Regional Spotlight

Featured Regional Spotlight

Paragon Welcomes Employees to New 151,000 sq/ft Gene Therapy Manufacturing Facility

Published by : Chris Frew
Published on : 31 Jul 2018
Featured Regional Spotlight

These Philosophies Have Propelled The Emmes Corporation to Become a Leading International Clinical Research Organization

Published by : Chris Frew
Published on : 30 Jul 2018
Regional Spotlight

Recap: Virginia Drug Discovery Rx: Symposium on Academic-Industrial Partnerships in Drug Discovery

Published by : Chris Frew
Published on : 1 Jul 2018

building a more connected biotech ecosystem

Categories